Table 1.

Patients characteristics

Characteristicn (%)
Gender
    Male51 (84%)
    Female10 (6%)
Age (y)
    Median55
    Range26-80
ECOG performance status
    0-158 (95%)
    2-33 (5%)
No. prior chemotherapy for metastatic disease
    Median2
    Range1-8
    1-242 (69%)
    ≥319 (31%)
No. metastatic sites
    Median3
    Range1-6
    1-231 (51%)
    ≥330 (49%)
Metastatic sites
    Lymph nodes31 (51%)
    Liver11 (18%)
    Lung43 (70%)
    Bone29 (48%)
    Brain8 (13%)
Baseline albumin (g/dL)
    Median4
    Range3-4.9
    <3.54 (7%)
    ≥3.557 (93%)
Baseline hemoglobin (g/dL)
    Median12.6
    Range9-16.2
    <10.58 (13%)
    ≥10.553 (87%)
Baseline LDH (U/dL)
    Median480
    Range270-4,660
    Normal LDH17 (28%)
    Elevated LDH44 (72%)
Tumor histology
    HNSCC38 (62%)
    ACC12 (20%)
    Other11 (18%)
RMH prognostic score
    Good (0-1)48 (79%)
    Poor (2-3)13 (21%)